◆ 会议时间：2023年5月21日至24日
◆ 会议地点：德国 曼海姆（Mannheim, Germany）

◆ 会议简介：

2023年第91届欧洲动脉粥样硬化学会(EAS)大会（年会）将于2023年5月21日至24日在德国曼海姆举行，会议由欧洲动脉粥样硬化学会(EAS)组织。

欧洲动脉硬化学会(EAS)成立于1964年，其宗旨是促进和交流有关动脉粥样硬化疾病的病因、自然史、治疗和预防的知识。50多年来，EAS的专业知识已经被用来教授临床医生如何管理管理血脂紊乱和如何预防动脉粥样硬化，通过向其成员提供教育材料与参加大会和课程的机会，以及提供一个可以讨论最新进展的论坛，EAS有助于宣该领域知识的发展，并最终改善心血管疾病和脂质紊乱患者的治疗。EAS每年在欧洲不同的城市组织一次为期3天的科学会议，约有2500名对心血管疾病感兴趣的基础和临床科学家、临床医生与行业从业者参加EAS大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

EAS 2023 - 91st European Atherosclerosis Society (EAS) Congress

DATE: Sunday May 21 - Wednesday May 24, 2023
VENUE: Congress Center Rosengarten Mannheim, Mannheim, Germany

摘要征文投稿：

Abstract Submission

Deadline: December 6, 2022 (midnight CET)

Notifications to submitters will be emailed by mid-February, 2023

点此提交摘要>>>Submit Abstract>>>

Rules for Submission:

• The presenting author is expected to attend the congress and present the poster or oral presentation.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
• ​All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.

Abstract submission and presentation rules

Submission

• All abstracts submitted via the online submission form before the deadline will be forwarded to the Abstract Review Committee for review.
• All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
• Abstracts submitted by fax or e-mail will not be accepted.
• Please do not submit multiple copies of the same abstract.

Confirmation of receipt & notification of decision

• You will receive email confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact the Secretariat if you submit an abstract and do not receive confirmation that it has been received.
• Notifications regarding status of your abstract will be sent once the review process is complete.

Presentation at Congress

• Instructions for preparation of oral or poster presentations will be sent together with acceptance notifications.
• The Committee will endeavour to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
• For each abstract, an author is expected to attend the congress and make the poster or oral presentation. Presenting authors must register by March 15, 2023.
• All accepted and presented abstracts for which a presenting author is registered and has paid the registration fee by March 15, 2023:
  – will be scheduled for presentation and included in the online Congress Scientific Programme.
  – will be included in the Congress proceedings in the Society’s journal, Atherosclerosis, in an issue to be published 3 months after the Congress.
• Abstracts for which no author has registered to attend Congress by March 16, 2023 will not be included in the Congress Scientific Programme.

Writing & submitting your abstract

Please follow the guidance below when writing and submitting your abstract. Failure to do so may result in your abstract receiving a low grade making it unsuitable for further consideration.

• The abstract should be as informative as possible
• Aim: state background and specific objective of study
• Methods: shortly describe methods used including
  • Design and setting of the study, clear description of interventions and comparisons
  • Human studies: characteristics of participants, including number, diagnosis, sex, and ethnicity as appropriate
  • Animal studies: report number of animals, species, strain, and genotype if relevant
  • Other studies: clear description of materials, such as cell lines and conditions
  • Type of statistical analyses used
• Results: summarize results obtained, report quantitative data, confidence intervals, and p values for comparisons
• Conclusions: state conclusions reached
• Standard abbreviations may be used.

Before you begin, please prepare the following information:

• Presenting author’s contact details:  
• Email address
• Full postal address
• Phone number
• Date of birth

Presentation type – please choose from one of the following:

• Oral presentation
• Poster presentation
• Science at a Glance Presentation (SaaG Poster)

Author and co-authors’ details:

• Full first and family name(s)
• Affiliation details: department, institution / hospital, city, state (if relevant), country

Abstract title – Limited to 25 words in Sentence Structure and including the study design if appropriate

Abstract text – Limited to 250 words (Please Note: Word count is not affected when graphs/tables/images are added).

Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.

Diagrams/Table/Images

• Prepare all images in JPG format before starting the process.
• If you wish to add more than one image/table/graphics, you must prepare a single JPG file and this should not exceed 200 Kbytes.
• The Organizing Secretariat will check all images and can decide to change their dimensions or reject them according to the publisher.

Declaration of Consent to Publication and Assignation of Copyright

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
• Submission of the abstract constitutes my consent to publication (e.g. congress website, programmes, other promotions, etc.)
• The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to EAS 2023 and Kenes International (Hereafter: “The Organisers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
• The Abstract Submitter grants the Organisers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content. 
• The Organisers reserve the right to remove from any publication an
  abstract which does not comply with the above.
• I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.

On behalf of the European Atherosclerosis Society (EAS) and the German societies DACH, DGFF and DGAF we are proud to invite you to participate in the 91st EAS Congress in the city of Mannheim. Mannheim is conveniently located in southern Germany with close access to Frankfurt and is home to inventions such as the automobile, bicycle and tractor. Plenty of cultural experiences and wine regions are within reach of the city.

The congress will carry on from the successful recent congress held in Milan and will offer in-person and virtual attendance. During the meeting we will explore the latest developments in basic, translational and clinical research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. One of the key features of our Congress is the high-level interdisciplinary exchange between clinicians and basic researchers. With many world-leading experts already confirmed, the EAS 2023 scientific programme will offer an overview of the latest current research in the field – including the award-winning Anitschkow Lecture, outstanding Keynote Lectures, state-of-the-art Plenary Sessions, and focused Workshops and Advance Clinical Seminars. We firmly believe that the personal meeting – presenting and discussing one’s work with others and sparking ideas from others’ work – is the key to progress in science. We encourage you to join us – to ask questions and share ideas during the Science at a Glance and Poster Sessions.

The EAS mission is also to support young scientists in progressing their careers through Young Investigator Fellowships. This important initiative offers early-career scientists the opportunity to take part in the Congress, to learn through presenting their own research, attending the scientific programme, and getting to know others in the field. Information about Fellowships can be found on the Society website, and we welcome abstract submissions from young scientists.

We are extremely happy to invite you to attend the EAS 2023 Congress in Mannheim, on May 21 – May 24. You are sure to gain new friends, new ideas, and inspiration to take your studies of atherosclerosis and related vascular disease to new levels!

Winfried März
Congress Chair

Ulrich Laufs
Congress Chair

Christoph Binder
Scientific Programme Committee Chair

Kausik Ray
EAS President

◆ 参会对象：医生、药剂师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。